Avalo Therapeutics Inc
Biotechnology
Healthcare
AVTX
10.83 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
11.79
52 week high
14.44
high
11.83
52 week low
0.00
previous Close
11.70
P/E ratio
-6
market cap
96.69 M
div yield
0
net incoming
-20.77 M
-57.92 %
net profit margin
-2076500000.00 %
0.00 %
operating incoming
-19.32 M
-31.68 %
net change in cash
-82.72 M
-774.69 %
cash on hand
42.31 M
-66.16 %
cost of revenue
134 K
0.00 %
top